AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NUTRITIONAL GROWTH SOLUTIONS LTD Capital/Financing Update 2024

Feb 18, 2024

65418_rns_2024-02-18_17724aee-05a0-43dd-9be5-9d37f089421f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX ANNOUNCEMENT | 19 FEB 2024

Convertible Notes issued on 14 February 2024

Nutritional Growth Solutions Limited (ASX:NGS) (" NGS " or " the Company ") refers to the 400,000 convertible notes issued on 14 February 2024 ( Convertible Notes ) and confirms that the issue of ordinary shares on conversion of the Convertible Notes is subject to shareholder approval for the purposes of ASX Listing Rule 7.1.

This announcement has been authorised for release by the Board.

For further information, please contact:

Stephen Turner Managing Director and CEO

[email protected]

About Nutritional Growth Solutions

Nutritional Growth Solutions is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into pediatric nutrition at Schneider Children’s Medical Centre, Israel’s largest pediatric hospital. The nutritional supplements market has experienced tremendous growth in recent years, but most attention has been focused on adult users and children under three years of age. The three to twelve-year-old consumers represent a larger market opportunity and NGS is highly differentiated from its competitors with clinically tested products and an expanding product portfolio to capture this market opportunity.

https://healthyheights.com/